(Q34556870)

English

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

scientific article

Statements

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. (English)
0 references
0 references
0 references
0 references
0 references
Luc F Van Gaal
Aila M Rissanen
André J Scheen
Olivier Ziegler
RIO-Europe Study Group
1389-1397

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit